Q2 2023

Source filing unavailable

Q2 2023 · —

Revenue

€4.83B

+1.4% vs Q2 2022

Net Income

€140.36M

−4.6% vs Q2 2022

EPS Diluted

€0.48

−4.0% vs Q2 2022

Operating Income€356,627,000+4.7%

Operating Cash Flowderived€1,007,144,000+34.0%

Margins · derived

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	€4.83B	€4.76B	€4.32B	€4.56B
Net Income	€140.36M	€147.14M	€218.58M	€350.97M
EPS Diluted	€0.48	€0.50	€0.75	€1.20

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR